Author:
Lee Ryugyoung,Ku Minhee,Je Nam Kyung
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Lindley C, Hirsch J, O’Neill C, Transau M, Gilbert C, Osterhaus J (1992) Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1(5):331–340
2. Viale PH, Grande C, Moore S (2012) Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs 16(4):E133–E141
3. Wozniak AJ, Crowley JJ, Balcerzak SP et al (1998) Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 16(7):2459–2465
4. Cohen L, De Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Antiemesis. Version 2.2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed March 23 2022